A nanocomposite competent to overcome cascade drug resistance in ovarian cancer via mitochondria dysfunction and NO gas synergistic therapy

• Principais autores: Min Zhong (Autor), Peiqin Liang (Autor), Zhenzhen Feng (Autor), Xin Yang (Autor), Guang Li (Autor), Rui Sun (Autor), Lijuan He (Autor), Jinxiu Tan (Autor), Yangpengcheng Xiao (Autor), Zhiqiang Yu (Autor), Muhua Yi (Autor), Xuefeng Wang (Autor)
• Formato: Livro
• Publicado em: Elsevier, 2023-11-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Ovarian cancer (OC) is one of the most common and recurring malignancies in gynecology. Patients with relapsed OC always develop ''cascade drug resistance'' (CDR) under repeated chemotherapy, leading to subsequent failure of chemotherapy. To overcome this challenge, amphiphiles (...